Mednax (MD) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mednax (MD) PT Raised to $80 at Jefferies
January 30, 2015 8:58 AM ESTJefferies analyst Brian Tanquilut reiterated a Buy rating and boosted his price target on Mednax (NYSE: MD) to $80.00 (from $69.00)
Tanquilut said, "The high level of bullishness expressed by mgmt. on their Q4 earnings call, in our view, underscore MD's solid position and robust growth... More
